Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identification Of New Asthma Genes Demonstrates A Model For Improved Patient Care

13.04.2004


An international team of researchers from the University of Helsinki, GeneOS Ltd. and partner institutions announced today that it has made significant discoveries on the causes of asthma. The team’s study, published in the April 9, 2004 edition of Science, reports two novel asthma genes and a set of diagnostic single nucleotide polymorphisms (SNPs).

The implications of the finding are that physicians may be able to identify atopic asthma and allergy patients earlier than is currently possible. Even more importantly, the gene that was found to be the risk gene for asthma is well suited for a drug target molecule.
Previous genome-wide scans in multiple populations have suggested that there is a susceptibility region for asthma on chromosome 7p. This study focused its efforts to confirm the hypothesis and to identify the genes in the Finnish families. The results were then replicated among the Canadian families to be sure that the findings are valid also in other populations. A hierarchical genotyping design was used and lead to the identification of a 133kb risk-conferring segment that contained two genes. The data imply that an orphan G-protein receptor named GPRA is involved in the pathogenesis of atopy and asthma and may have application in other inflammatory diseases.


“The importance of this discovery is that our findings validate our approach of being able to build relevant patient databases and use this information to understand disease outcome”, said Tarja Laitinen, Chief Scientific Officer, GeneOS. “Additionally, these findings are very relevant for our company because they show how we can use information generated in Finland and apply it to other populations. GeneOS is building its capabilities to study disease outcomes in Finland to help pharmaceutical and medical device companies design and run clinical trials and better understand patient response. Findings like the GPRA gene will lead to better diagnosis and treatment.”

“This research is a culmination of ten-year project to identify genes for complex diseases”, said Professor Juha Kere from Karolinska Institutet (Sweden) and University of Helsinki. “Other, similar findings may become reality from comparable efforts, building on the excellent Finnish and Scandinavian medical and population data.”

The number of asthmatics has been growing at about 10 % per year; currently asthma affects approximately 6-10 % of the population in the United States and Western Europe. Asthma accounts for approximately 10 % of all prescription drug spending in the United States and Western Europe. Treatment plans are complex and the ability to measure improved outcome is poor. The ability to study outcomes in Finland and then confirm the findings in other populations will help improve treatment for patients worldwide.

For further information please contact:
Juha Kere, Professor, Helsinki University and Karolinska Institutet, +46 7 3421 3550, juha.kere@biosci.ki.se (about discovery)

Tarja Laitinen, Chief Scientific Officer, GeneOS Ltd., + 358 50 534 6238,tarja.laitinen@geneos.fi (about discovery and GeneOS)

Steve Lehrer, CEO, GeneOS Inc. +1 650 269 3420,
steve@sblehrer.com (about GeneOs)

Paivi Lehtinen | alfa
Further information:
http://www.helsinki.fi

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>